Public offer to the shareholders of Recipharm AB – SEK 25.0 billion Healthcare Public offer to the shareholders of Recipharm AB – SEK 25.0 billion
Bond tap issue by Humble Group AB (SE) — SEK 200 million Consumer & Retail Bond tap issue by Humble Group AB (SE) — SEK 200 million
Directed share issue in Nordic Entertainment Group AB (SE) — SEK 4.35 billion TMT Directed share issue in Nordic Entertainment Group AB (SE) — SEK 4.35 billion
Private placement in Omaken Sports AS (NO) and subsequent registration on Euronext NOTC — NOK 150 million TMT Private placement in Omaken Sports AS (NO) and subsequent registration on Euronext NOTC — NOK 150 million
Private placement in Airmee (SE) — SEK 160 million Consumer & Retail Private placement in Airmee (SE) — SEK 160 million
Initial public offering of Nimbus Group AB (SE) on Nasdaq First North Growth Market – SEK 512 million Consumer & Retail Initial public offering of Nimbus Group AB (SE) on Nasdaq First North Growth Market – SEK 512 million
Initial public offering of Fractal Gaming Group AB (SE) on Nasdaq First North Premier Growth Market – SEK 550 million TMT Initial public offering of Fractal Gaming Group AB (SE) on Nasdaq First North Premier Growth Market – SEK 550 million
Private placement in Panoro Energy ASA (NO) – USD 70 million Oil & Gas Private placement in Panoro Energy ASA (NO) – USD 70 million
Sale of Advisa AB (SE) to Nordic Capital (SE) – Amount not disclosed FIG Sale of Advisa AB (SE) to Nordic Capital (SE) – Amount not disclosed
Directed share issue in BHG Group AB (SE) — SEK 1.7 billion Consumer & Retail Directed share issue in BHG Group AB (SE) — SEK 1.7 billion
Directed share issue in Paxman AB (SE) — SEK 60 million Healthcare Directed share issue in Paxman AB (SE) — SEK 60 million
Rights issue in InDex Pharmaceuticals Holding AB (SE) — SEK 533 million Healthcare Rights issue in InDex Pharmaceuticals Holding AB (SE) — SEK 533 million